CLAIMSFILER ALERTS NOVAVAX Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX

·2 min read

NEW ORLEANS, Dec. 1, 2021 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors with losses in excess of $100,000 that they have until January 11, 2022 to file lead plaintiff applications in a securities class action lawsuit against Novavax, Inc. (NasdaqGS: NVAX), if they purchased the Company's securities between March 2, 2021 and October 19, 2021, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Maryland.

Get Help
Novavax investors should visit us at or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit
Novavax and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On August 5, 2021, the Company disclosed another delay in filing the Emergency Use Authorization ("EUA") for its COVID-19 vaccine product candidate, NVX-CoV2373, from the third quarter of 2021 to the fourth quarter of 2021. On this news, Novavax's stock price fell $46.31 per share, or 19.61%, to close at $189.89 per share on August 6, 2021. Then, on October 19, 2021, Politico reported that anonymous sources stated that manufacturing issues could delay regulatory authorizations and approvals for NVX-CoV2373 until the end of 2022.

On this news, Novavax's shares plummeted $23.69 per share, or 14.76%, to close at $136.86 per share on October 20, 2021.

The case is Sinnathurai v. Novavax, et al., 21-cv-02910.

About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit


View original content:

SOURCE ClaimsFiler

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting